Add time:08/13/2019 Source:sciencedirect.com
We report the application of cationic tri- and tetra-nuclear gold(I) phosphine complexes [Au3(μ-dppen)3]X3 and [Au4(μ-dppa)4]X4 (X = OTf, PF6) [OTf = trifluoromethanesulfonate, dppen = trans-1,2-bis(diphenylphosphino)ethene, dppa = bis(diphenylphosphino)acetylene] for cancer treatment. The results of cytotoxicity tests on four different cancer cells [prostate (DU145), cervical (HeLa), breast (MDAMB-231) and fibro sarcoma (HT1080)] indicate these complexes possess remarkable tumor cell growth inhibitory effects and high selectivity towards cancer cells. The anti-tumor mechanism of the tri- and tetra-nuclear gold(I) complexes has also been investigated.
We also recommend Trading Suppliers and Manufacturers of bis(1,2-bis(diphenylphosphino)ethene)gold (I) (cas 116449-44-6). Pls Click Website Link as below: cas 116449-44-6 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View